Refining Patient Reported Outcomes
Chad Gwaltney, Ph.D.
– Scientist
A full-time scientist with PRO Consulting, Chad Gwaltney most recently worked as an Assistant Professor (Research) in the Department of Community Health at Brown University. In his research, Dr. Gwaltney has employed ecological momentary assessment methods to collect patient self-report data in both adults and adolescents. He has published over 20 articles and book chapters addressing topics such as addictive behaviors, cardiovascular health, and statistical methods for intensive self-report data. Dr. Gwaltney is also an investigator on 3 NIH-funded grants and serves as a manuscript reviewer for several academic journals. Dr. Gwaltney received his bachelor's degree from the University of Rhode Island and his Ph.D. in Clinical-Health Psychology from the University of Pittsburgh. He was a pre-doctoral fellow in the NHLBI/University of Pittsburgh Cardiovascular Behavioral Medicine Program and received his graduate clinical training at the Western Psychiatric Institute and Clinic. He completed his clinical psychology internship in the Department of Psychiatry and Human Behavior at Brown University.
Where to find Chad:
21 April 2009 - ePROficiency™ 2009: invivodata’s global ePRO Conference; Naples, FL
Dr. Gwaltney will join other industry and regulatory experts at this inaugural conference which is focused on the effective capture of PROs in clinical research. For more information, visit www.invivodata.com/epro2009
16 May 2009 - ISPOR 14th Annual International Meeting; Orlando, FL
Dr. Chad Gwaltney will lead a workshop presentation on “Establishing the Content Validity of PRO Instruments”. For more information, visit www.ispor.org
Webinar Replay: "How much do you know about the FDA Draft Guidance?”
Dr. Gwaltney leads an interactive Web Seminar that explores various elements of the FDA’s Draft Guidance on PROs in Clinical Research, including answers to the top 10 questions often asked by clinical researchers. View Webinar today!
Webinar Replay: Migration of PRO Measures from Paper to Electronic: Theoretical & Practical Perspectives
Dr. Gwaltney conducted a discussion of the validation activities required to migrate PRO measures from paper to electronic; a discussion on the recent meta-analysis on the impact of moving from paper to electronic, and practical strategies to successfully migrate from paper to electronic in the context of the FDA draft PRO Guidance. View webinar today!